-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RAB-001 in Osteoporosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RAB-001 in Osteoporosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RAB-001 in OsteoporosisDrug Details:RAB-001 is under development for the treatment of osteoporosis, osteonecrosis, fracture...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – RAB-001 in Osteonecrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - RAB-001 in Osteonecrosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.RAB-001 in OsteonecrosisDrug Details:RAB-001 is under development for the treatment of osteoporosis, osteonecrosis, fracture...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Maplirpacept in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Maplirpacept in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Maplirpacept in Relapsed Multiple MyelomaDrug Details:Maplirpacept (TTI-622) is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – RAB-001
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry RAB-001 Drug Details RAB-001 is under development for the treatment of osteoporosis, osteonecrosis, fracture...
-
Product Insights
Osteonecrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Osteonecrosis is bone death caused by the poor blood supply to the area. It is most common in the hip and shoulder but can affect other large joints such as the knee, elbow, wrist, and ankle. Osteonecrosis can be caused by disease, or severe trauma, such as a break or dislocation, that affects the blood supply to the bone. There are no symptoms in the early stages. The Osteonecrosis pipeline drugs market report provides comprehensive information on the therapeutics under...
-
Product Insights
Rheumatoid Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Rheumatoid arthritis (RA) is an autoimmune chronic disorder that eventually leads to the destruction of bones causing deformities. Signs and symptoms of rheumatoid arthritis include tender, warm, swollen joints, fatigue and fever, and weight loss. Treatment includes non-steroidal anti-inflammatory drugs, corticosteroid medications, and immunosuppressants. The Rheumatoid Arthritis Drugs in Development market research report provides an overview of the Rheumatoid Arthritis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rheumatoid Arthritis, complete with analysis by stage...
-
Product Insights
Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
Integrin Alpha 4 is a protein encoded by ITGA4. This integrin is a therapeutic target for the treatment of multiple sclerosis, Crohn's disease, and inflammatory bowel disease. The Integrin Alpha 4 drugs in development market research report provides in-depth analysis of Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) targeted pipeline therapeutics. The report provides comprehensive information on the Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit...
-
Product Insights
Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2021 Update
According to the recently published report 'Indoleamine 2,3 Dioxygenase 1 - Drugs in Development, 2021'; Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) pipeline Target constitutes close to 38 molecules. Out of which approximately 32 molecules are developed by companies and remaining by the universities/institutes. Indoleamine 2,3 Dioxygenase 1 (Indoleamine Pyrrole 2,3 Dioxygenase 1 or IDO1 or EC 1.13.11.52) - Indoleamine-pyrrole 2, 3-dioxygenase 1 is a heme-containing enzyme encoded by the IDO1 gene. This...
-
Sector Analysis
United States (USA) Orthopedic Devices Market Size (Value, Volume, ASP) by Segments (Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction and Others), Share and Forecast, 2015-2025
GlobalData’s “United States Orthopedic Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the United States Orthopedic Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Orthobiologics, Orthopedic Bone Cement and Casting Materials, Orthopedic Power Tools and Consumables, Other Joint Reconstruction, Shoulder Replacement, Spinal Surgery and Trauma Fixation. The United States Orthopedic Devices Market report provides...